Literature DB >> 31593274

Pancreatic Cancer.

Alexandra Moore1, Timothy Donahue1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31593274      PMCID： PMC7021307          DOI： 10.1001/jama.2019.14699

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  35 in total

1.  A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.

Authors:  Duo Liu; Dan Zhou; Yanfa Sun; Jingjing Zhu; Dalia Ghoneim; Chong Wu; Qizhi Yao; Eric R Gamazon; Nancy J Cox; Lang Wu
Journal:  Cancer Res       Date:  2020-09-09       Impact factor: 12.701

2.  Prognostic role of IRS-4 in the survival of patients with pancreatic cancer.

Authors:  Miguel A Ortega; Leonel Pekarek; Cielo Garcia-Montero; Oscar Fraile-Martinez; Miguel A Saez; Angel Asúnsolo; Miguel A Alvarez-Mon; Jorge Monserrat; Santiago Coca; M Val Toledo-Lobo; Natalio García-Honduvilla; Agustin Albillos; Julia Buján; Melchor Alvarez-Mon; Luis G Guijarro
Journal:  Histol Histopathol       Date:  2022-02-09       Impact factor: 2.303

3.  Risk factors and prognostic index model for pancreatic cancer.

Authors:  Hui Huang; Jichun Sun; Zheming Jiang; Xianlin Zhang; Zheng Li; Hongwei Zhu; Xiao Yu
Journal:  Gland Surg       Date:  2022-01

4.  Impact of the tumor immune microenvironment on the outcome of pancreatic cancer: a retrospective study based on clinical pathological analysis.

Authors:  Hui Huang; Jichun Sun; Zhiqiang Li; Xianlin Zhang; Zheng Li; Hongwei Zhu; Xiao Yu
Journal:  Gland Surg       Date:  2022-02

Review 5.  The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.

Authors:  Qing Zhang; Wen Wen Chen; Xue Sun; Die Qian; Dan Dan Tang; Li Lin Zhang; Mei Yan Li; Lin Yu Wang; Chun-Jie Wu; Wei Peng
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

6.  Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis.

Authors:  Daolin Ji; Li Hou; Chunyang Xie; Haonan Feng; Dongdong Bao; Yue Teng; Junhao Liu; Tiangang Cui; Xiuhong Wang; Yi Xu; Gang Tan
Journal:  J Oncol       Date:  2022-06-25       Impact factor: 4.501

7.  N6-methyladenosine methylation modification patterns reveal immune profiling in pancreatic adenocarcinoma.

Authors:  Hao Xu; Lu Yin; Qianhui Xu; Jingjing Xiang; Rujun Xu
Journal:  Cancer Cell Int       Date:  2022-05-23       Impact factor: 6.429

8.  Characterization of the Immune Cell Infiltration Profile in Pancreatic Carcinoma to Aid in Immunotherapy.

Authors:  Fei Kuang; Juan Du; Mengjia Zhou; Fangyi Peng; Yu Gan; Cheng Fang; Xiaoli Yang; Bo Li; Song Su
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

Review 9.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

10.  Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis.

Authors:  Rong Tang; Qingcai Meng; Wei Wang; Chen Liang; Jie Hua; Jin Xu; Xianjun Yu; Si Shi
Journal:  Gland Surg       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.